The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...

Fact checked by Jennifer Klump About the Author Kelly Wood, MD, is a board-certified endocrinologist specializing in osteoporosis and metabolic bone disease. She also treats adults with diabetes, ...

Hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning ...

If a night of sleep leaves you waking up tired, you could have an undiagnosed condition that’s risking your health. Know that ...

A new pooled analysis led by UCSF researchers suggests that how your brain looks during sleep, its so‑called brain age, may help predict who goes on to develop dementia. In roughly 7,100 U.S. adults ...

Struggling to get a good night’s rest? You’re not alone. According to a recent study by Nice Rx, La. adults rank as the fourth most sleep-deprived ...

Dr. Negar Eslami, DDS, explains how custom oral appliances help Austin couples sleep better, breathe easier, and wake up healthier — without a CPAP machine. We don’t just treat snoring — we uncover ...

LivaNova (Nasdaq:LIVN) announced today that it received FDA premarket approval (PMA) for its aura6000 neuromodulation system for sleep apnea.

GLP-1 medications, such as Ozempic, Zepbound and Wegovy, have emerged as a significant advancement in the treatment of various conditions, including Type 2 diabetes, heart ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the ...

Incannex Healthcare Inc. (Nasdaq: IXHL) , a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 ...